Therapeutic effectiveness and tolerability of aripiprazole as initial choice of treatment in first episode psychosis in an early intervention service: A one-year outcome study.. Schizophr Res. 174(1-3):120-5.. 2016.
Real-life assessment of aripiprazole monthly (Abilify Maintena) in schizophrenia: a Canadian naturalistic non-interventional prospective cohort study.. BMC Psychiatry. 19(1):114.. 2019.
Progress of negative symptoms over the initial 5 years of a first episode of psychosis - CORRIGENDUM.. Psychol Med. :1-3.. 2018.
Progress of negative symptoms over the initial 5 years of a first episode of psychosis.. Psychol Med. :1-9.. 2018.
Predictors of 'all-cause discontinuation' of initial oral antipsychotic medication in first episode psychosis.. Schizophr Res.. 2018.
A NEET distinction: youths not in employment, education or training follow different pathways to illness and care in psychosis.. Soc Psychiatry Psychiatr Epidemiol.. 2018.
Look Before You Leap: Representativeness of Those Completing Self-Reports in Early Psychosis Research.. Can J Psychiatry. :706743719879356.. 2019.
Effectiveness of Community Treatment Order in Patients with a First Episode of Psychosis: A Mirror-Image Study.. Can J Psychiatry. :706743718777389.. 2018.
Early Stabilization of Weight Changes Following Treatment With Olanzapine, Risperidone, and Aripiprazole: A 12-Month Naturalistic Study of First Episode Psychosis.. J Clin Psychiatry. 80(5). 2019.
Corrigendum to "Therapeutic Effectiveness and Tolerability of Aripiprazole as Initial Choice of Treatment in First Episode Psychosis in an Early Intervention Service: A One-Year Outcome Study" [Schizophr. Res. 147, 120-125].. Schizophr Res. 193:490.. 2018.